Dr Fielding is currently the Director of Technology Transfer at IP Group plc, the intellectual property commercialisation company. She has five years' experience in identifying and commercialising a diverse range of new technologies, encompassing electronics, software, remote power sources, speciality chemicals, medical devices and pharmaceuticals, and over eleven years' experience of managing companies in a senior capacity.
Previously, she spent five years at McKinsey & Co where she consulted on issues such as business strategy, international growth, organisational design and financial turnaround. Prior to McKinsey, Dr. Fielding spent four years as a development chemist for Zeneca, where she worked commercialising new technologies in the speciality chemicals and agrochemicals divisions. She holds an MBA with distinction from Manchester Business School, a PhD in organic chemistry and a first class degree in chemistry from the University of Glasgow.
As announced in the circular to shareholders, dated 1 August 2006, John Cook has informed the board of his intention to retire as a board director now that a new board director has been appointed and he will step down at the end of October 2006.
Dick Eykel, Chairman of COE Group, said: "John has worked tirelessly for COE for 15 years and we are very grateful for his important contribution to the Company."
Andrew Wallace, Chief Executive of COE Group, said: "We are delighted that Dr Fielding has joined the Board of Directors. Her experience of commercialising new technologies, her detailed knowledge of IP Group's portfolio and her professional background will be a great asset to COE."
More on COE Group plc